Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2000 Jan;91(1):84–90. doi: 10.1111/j.1349-7006.2000.tb00863.x

Expression of Drug Resistance‐related Genes in Head and Neck Squamous Cell Carcinoma and Normal Mucosa

Shitau Hirata 1,✉, Osamu Katoh 3, Tetsuya Oguri 2, Hiromitsu Watanabe 3, Koji Yajin 1
PMCID: PMC5926219  PMID: 10744048

Abstract

We examined the expression levels of mRNA for multidrug resistance 1 (MDR1), multidrug resistance‐associated protein (MRP), human canalicular multispecific organic anion transporter (cMOAT), lung resistance‐related protein (LRP), topoisomerase IIα, β(Topo IIα, β) and topoisomerase I (Topo I) genes in human head and neck squamous cell carcinoma (HNSCC) specimens and mucosa (HNM) specimens, to elucidate their roles in relation to the biological characteristics and drug resistance in vivo. Fifty‐eight samples (45 head and neck carcinomas and 13 head and neck mucosa) obtained during surgical resection or biopsy from 38 patients were analyzed using the quantitative reverse transcription‐polymerase chain reaction (RT‐PCR) method. MDR1, MRP, LRP, Topo IIα, Topo IIβ, and Topo I gene transcripts were detected in all the samples tested, but cMOAT mRNA was not detected in them. Comparisons of the expression levels in HNSCC with those in HNM showed that the Topo IIα gene expression level was higher in HNSCC than in HNM (P=0.0298). Moreover, the Topo IIα mRNA level was significantly higher in metastatic lymph node samples of HNSCC than in HNM samples (P=0.0205). There were no significant differences in the six genes' expression levels between samples exposed to platinum drugs and those not exposed to platinum drugs. These results suggest that it may be effective in anticancer therapy to use topoisomerase‐targetting drugs against HNSCC, especially metastatic neck tumors, and that the expression of these genes in HNSCC is not associated with platinum drug exposure.

Keywords: DNA topoisomerase II, Drug resistance‐related gene, Head and neck squamous cell carcinoma

Full Text

The Full Text of this article is available as a PDF (102.3 KB).

REFERENCES

  • 1. ) Chen , C. , Chin , J. E. , Ueda , K. , Clark , D. P. , Pastan , I. , Gottesman , M. M. and Roninson , I. B.Internal duplication and homology with bacterial transport proteins in the mdr1(P‐glycoprotein) gene from multidrug‐resistant human cells . Cell , 47 , 381 – 389 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Gottesman , M. M. and Pastan , I.Biochemistry of multidrug resistance mediated by the multidrug transporter . Annu. Rev. Biochem. , 62 , 385 – 427 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Germann , U. A.P‐Glycoprotein—a mediator of multidrug resistance in tumour cells . Eur. J. Cancer , 32A , 927 – 944 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Loe , D. W. , Deeley , R. G. and Cole , S. P. C.Biology of the multidrug resistance‐associated protein, MRP . Eur. J. Cancer , 32A , 945 – 957 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Taniguchi , K. , Wada , M. , Kohno , K. , Nakamura , T. , Kawabe , T. , Kawakami , M. , Kagotani , K. , Okumura , K. , Akiyama , S. and Kuwano , M.A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressied in cisplatin‐resistant human cancer cell lines with decreased drug accumulation . Cancer Res. , 56 , 4124 – 4129 ( 1996. ). [PubMed] [Google Scholar]
  • 6. ) Izquierdo , M. A. , Scheffer , G. L. , Flens , M. J. , Schroeijers , A. B. , van der Valk , P. and Scheper , R. J.Major vault protein LRP‐related multidrug resistance . Eur. J. Cancer , 32A , 979 – 984 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Zhou , D. C. , Zittoun , R. and Marie , J. P.Expression of multidrug resistance‐associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia . Leukemia , 9 , 1661 – 1666 ( 1995. ). [PubMed] [Google Scholar]
  • 8. ) Hasegawa , S. , Abe , T. , Naito , S. , Kotoh , S. , Kumazawa , J. , Hipfner , D. R. , Cole , S. P. C. and Kuwano , M.Expression of multidrug resistance‐associated protein (MRP), MDR1, and DNA topoisomerase II in human multidrug‐resistant bladder cancer cell lines . Br. J. Cancer , 71 , 907 – 913 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Fairchild , C. R. , Ivy , S. P. , Rushmore , T. , Lee , G. , Koo , P. , Goldsmith , M. E. , Myers , C. E. , Farber , E. and Cowan , K. H.Carcinogen‐induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas . Proc. Natl. Acad. Sci. USA , 84 , 7701 – 7705 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Nitiss , J. L. and Beck , W. T.Antitopoisomerase drug action and resistance . Eur. J. Cancer , 32A , 958 – 966 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Wang , J. C.DNA topoisomerases: why so many ? J. Biol. Chem. , 266 , 6659 – 6662 ( 1991. ). [PubMed] [Google Scholar]
  • 12. ) Drake , F. H. , Hofmann , G. A. , Bartus , H. F. , Mattern , M. R. , Crooke , S. T. and Mirabelli , C. K.Biochemical and pharmacological properties of p 170 and p 180 forms of topoisomerase II . Biochemistry , 28 , 8154 – 8160 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Woessner , R. D. , Mattern , M. R. , Mirabelli , C. K. , Johnson , R. K. and Drake , F. H.Proliferation‐ and cell cycle‐dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH‐3T3 cells . Cell Growth Differ. , 2 , 209 – 214 ( 1991. ). [PubMed] [Google Scholar]
  • 14. ) Meyer , K. N. , Kjeldsen , E. , Straub , T. , Knudsen , B. R. , Hickson , I. D. , Kikuchi , A. , Kreipe , H. and Boege , F.Cell cycle‐coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities . J. Cell Biol. , 136 , 775 – 788 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Chen , A. Y. and Liu , L. F.DNA topoisomerases: essential enzymes and lethal targets . Annu. Rev. Pharmacol. Toxicol. , 34 , 191 – 218 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Cornarotti , M. , Capranico , G. , Bohm , S. , Oriana , S. , Spatti , G. B. , Mariani , L. , Ballabio , G. and Zunino , F.Gene expression of DNA topoisomerases I, IIα and IIβ and response to cisplatin‐based chemotherapy in advanced ovarian carcinoma . Int. J. Cancer , 67 , 479 – 484 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Giaccone , G. , van Ark‐Otte , J. , Scagliotti , G. , Capranico , G. , van der Valk , P. , Rubio , G. , Dalesio , O. , Lopez , R. , Zunio , F. , Walboomers , J. and Pinedo , H. M.Differential expression of DNA topoisomerases in non‐small cell lung cancer and normal lung . Biochim. Biophys. Acta , 1264 , 337 – 346 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Syahruddin , E. , Oguri , T. , Takahashi , T. , Isobe , T. , Fujiwara , Y. and Yamakido , M.Differential expression of DNA topoisomerase IIα and IIβ genes between small cell and non‐small cell lung cancer . Jpn. J. Cancer Res. , 89 , 855 – 861 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Ohashi , N. , Fujiwara , Y. , Yamaoka , N. , Katoh , O. , Satow , Y. and Yamakido , M.No alteration in DNA topoisomerase I gene related to CPT‐11 resistance in human lung cancer . Jpn. J. Cancer Res. , 87 , 1280 – 1287 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Giaccone , G. , Gazdar , A. F. , Beck , H. , Zunino , F. and Capranico , G.Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression . Cancer Res. , 52 , 1666 – 1674 ( 1992. ). [PubMed] [Google Scholar]
  • 21. ) Giovanella , B. C. , Stehlin , J. S. , Wall , M. E. , Wani , M. C. , Nicholas , A. W. , Liu , L. F. , Silber , R. and Potmesil , M.DNA topoisomerase I‐targeted chemotherapy of human colon cancer in xenografts . Science , 246 , 1046 – 1048 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Bader , P. , Fuchs , J. , Wenderoth , M. , von Schweinitz , D. , Niethammer , D. and Beck , J. F.Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamicin or cisplatin . Anticancer Res. , 18 , 3127 – 3132 ( 1998. ). [PubMed] [Google Scholar]
  • 23. ) Koike , K. , Abe , T. , Hisano , T. , Kubo , T. , Wada , M. , Kohno , K. and Kuwano , M.Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins . Jpn. J. Cancer Res. , 87 , 765 – 772 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Oguri , T. , Fujiwara , Y. , Isobe , T. , Katoh , O. , Watanabe , H. and Yamakido , M.Expression of γ‐glutamylcysteine synthetase (γ‐GCS) and multidrug resistance‐associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancer to platinum drugs . Br. J. Cancer , 77 , 1089 – 1096 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. ) Abe , Y. , Nakamura , M. , Ota , E. , Ozeki , Y. , Tamai , S. , Inoue , H. , Ueyama , Y. , Ogata , T. and Tamaoki , N.Expression of the multidrug resistance gene (MDR1) in non‐small cell lung cancer . Jpn. J. Cancer Res. , 85 , 536 – 541 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Kreisholt , J. , Sorensen , M. , Jensen , P. B. , Nielsen , B. S. , Anderson , C. B. and Sehested , M.Immunohistochemical detection of DNA topoisomerase IIα, P‐glycoprotein and multidrug resistance protein (MRP) in small‐cell and non‐small‐ cell lung cancer . Br. J. Cancer , 77 , 1469 – 1473 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Oguri , T. , Fujiwara , Y. , Ochiai , M. , Fujitaka , K. , Miyazaki , M. , Takahashi , T. , Yokozaki , M. , Isobe , T. , Ohune , T. , Tsuya , T. , Katoh , O. and Yamakido , M.Expression of lung‐resistance protein gene is not associated with platinum drug exposure in lung cancer . Anticancer Res. , 18 , 4159 – 4162 ( 1998. ). [PubMed] [Google Scholar]
  • 28. ) Kim , W. J. , Kakehi , Y. , Kinoshita , H. , Arao , S. , Fukumoto , M. and Yoshida , O.Expression patterns of multidrug‐resistance (MDR1), multidrug resistance‐associated protein (MRP), glutathione S‐transferase‐π (GST‐π) and topoisomerase II (TopoII) genes in renal cell carcinomas and normal kidney . J. Urol. , 156 , 506 – 511 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Kakehi , Y. , Wu , W.‐J. , Kim , W.‐J. , Arao , S. , Fukumoto , M. and Yoshida , O.Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers . Int. J. Urol. , 2 , 309 – 315 ( 1995. ). [PubMed] [Google Scholar]
  • 30. ) Sandri , M. I. , Hochhauser , D. , Ayton , P. , Camplejohn , R. C. , Whitehouse , R. , Turley , H. , Gatter , K. , Hickson , I. D. and Harris , A. L.Differential expression of the topoisomerase IIα and β genes in human breast cancers . Br. J. Cancer , 73 , 1518 – 1524 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. ) Schneider , J. , Rubio , M. P. , Barbazan , M.J. , Rodriguez , E. F. J. , Seizinger , B. R. and Castresana , J. S.P‐Glycoprotein, HER‐2/neu, and mutant p53 expression in human gynecologic tumors . J. Natl. Cancer Inst. , 86 , 850 – 858 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Izquierdo , M. A. , van der Zee , A. G. J. , Vermorken , J. B. , van der Valk , P. , Beliën , J. A. M. , Giaccone , G. , Scheffer , G. L. , Flens , M. J. , Pinedo , H. M. , Kenemans , P. , Meijer , C. J. L. M. , de Vries , E. G. E. and Scheper , R. J.Drug resistance‐associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma . J. Natl. Cancer Inst. , 871230 – 1237 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) van der Zee , A. G. J. , Hollema , H. , de Jong , S. , Boonstra , H. , Gouw , A. , Willemse , P. H. B. , Zijlstra , J. G. and de Vries , E. G. E.P‐Glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy . Cancer Res. , 51 , 5915 – 5920 ( 1991. ). [PubMed] [Google Scholar]
  • 34. ) Ito , K. , Fujimori , M. , Kohno , K. , Nakagawa , A. , Kuwano , M. and Amano , J.Expression of multidrug resistance associated genes in paired cases of breast cancers and adjacent normal breast tissues . Proc. Am. Assoc. Cancer Res. , 38 , 388 ( 1997. ). [Google Scholar]
  • 35. ) Yamazaki , K. , Isobe , H. , Hanada , T. , Betsuyaku , T. , Hasegawa , A. , Hizawa , N. , Ogura , S. and Kawakami , Y.Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines . Cancer Chemother. Pharmacol. , 39 , 192 – 198 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Nooter , K. , Westerman , A. M. , Flens , M. J. , Zaman , G. J. R. , Scheper , R. J. , van Wingerden , K. E. , Burger , H. , Oostrum , R. , Boersma , T. , Sonneveld , P. , Gratama , J. W. , Kok , T. , Eggermont , A. M. M. , Bosman , F. T. and Stoter , G.Expression of the multidrug resistance‐associated protein (MRP) gene in human cancers . Clin. Cancer Res. , 1 , 1301 – 1310 ( 1995. ). [PubMed] [Google Scholar]
  • 37. ) Schadendorf , D. , Makki , A. , Stahr , C. , van Dyck , A. , Wanner , R. , Scheffer , G. L. , Flens , M. J. , Scheper , R. and Henz , B. M.Membrane transport proteins associated with drug resistance expressed in human melanoma . Am. J. Pathol. , 147 , 1545 – 1552 ( 1995. ). [PMC free article] [PubMed] [Google Scholar]
  • 38. ) Izquierdo , M. A. , Scheffer , G. L. , Flens , M. J. , Giaccone , G. , Broxterman , H. J. , Meijer , C. J. L. M. , van der Valk , P. and Scheper , R. J.Broad distribution of the multidrug resistance‐related vault lung resistance protein in normal human tissues and tumors . Am. J. Pathol. , 148 , 877 – 887 ( 1996. ). [PMC free article] [PubMed] [Google Scholar]
  • 39. ) Kelley , D. J. , Pavelic , Z. P. , Gapany , M. , Stambrook , P. , Pavelic , L. , Gapany , S. and Gluckman , J. L.Detection of P‐glycoprotein in squamous cell carcinomas of the head and neck . Arch. Otolaryngol. Head Neck Surg. , 119 , 411 – 414 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 40. ) Tsuzuki , H. , Saito , H. , Ohtsubo , T. , Tanaka , N. , Noda , I. , Sugimoto , C. , Tsuda , G. and Imamura , Y.Immunohistochemical detection of P‐glycoprotein and chemosensitivity from ATP assay in human head and neck malignant tumor . Head Neck Cancer , 22 , 1 – 6 ( 1996. ). [Google Scholar]
  • 41. ) Welters , M. J. P. , Fichtinger‐Schepman , A. M. J. , Baan , R. A. , Flens , M. J. , Scheper , R. J. and Braakhuis , B. J. M.Role of glutathione, glutathione S‐transferases and multidrug resistance‐related proteins in cisplatin sensitivity of head and neck cancer cell lines . Br. J. Cancer , 77 , 556 – 561 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. ) Saito , H. , Tanaka , N. , Sugimoto , C. and Tsuzuki , H.Anticancer drug resistance and approaches to overcoming it in head and neck cancer . Pract. Otol. (Kyoto) , 90 , 607 – 614 ( 1997. ). [Google Scholar]
  • 43. ) Duensing , S. , Dallmann , I. , Grosse , J. , Buer , J. , Hänninen , E. L. , Deckert , M. , Störkel , S. , Kirchner , H. , Poliwoda , H. and Atzpodien , J.Immunohistochemical detection of P‐glycoprotein: initial expression correlates with survival in renal cell carcinoma patients . Oncology , 51 , 309 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 44. ) Izquierdo , M. A. , Shoemaker , R. H. , Flens , M. J. , Scheffer , G. L. , Wu , L. , Prather , T. R. and Scheper , R. J.Overlapping phenotypes of multidrug resistance among panels of human cancer‐cell lines . Int. J. Cancer , 65 , 230 – 237 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 45. ) Ishikawa , T. , Bao , J. J. , Yamane , Y. , Akimaru , K. , Frindrich , K. , Wright , C. D. and Kuo , M. T.Coordinated induction of MRP/GS‐X pump and gamma‐glutamylcysteine synthetase by heavy metals in human leukemia cells . J. Biol. Chem. , 271 , 14981 – 14988 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 46. ) Horikoshi , T. , Danenberg , K. D. , Stadlbauer , T. H. W. , Volkenandt , M. , Shea , L. C. C. , Aigner , K. , Gustavsson , B. , Leichman , L. , Frosing , R. , Ray , M. , Gibson , N. W. , Spears , C. P. and Danenberg , P. V.Quantitation of thymidylate synthase, dihydrofolate reductase, and DT‐diaphorase gene expression in human tumors using the polymerase chain reaction . Cancer Res. , 52 , 108 – 116 ( 1992. ). [PubMed] [Google Scholar]
  • 47. ) Ishikawa , Y. , Kubota , T. , Otani , Y. , Watanabe , M. , Teramato , T. , Kumai , K. , Kitajima , M. , Takechi , T. , Okabe , H. and Fukushima , M.Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the anticancer effect of 5‐fluorouracil on human tumor xenografts in nude mice . Clin. Cancer Res. , 5 , 883 – 889 ( 1999. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES